Patricio Godoy
Dortmund, NW 44139, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIII.
Journal: Journal of pharmaceutical sciences
Published: July 09, 2025
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
Journal: Biochemical and biophysical research communications
Published: May 24, 2024
Application of a gut-liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil.
Journal: Lab on a chip
Published: July 14, 2022
Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies.
Journal: Lab on a chip
Published: February 02, 2022
Correction to: Toxicogenomics directory of chemically exposed human hepatocytes.
Journal: Archives of toxicology
Published: January 31, 2022
Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity.
Journal: Hepatology (Baltimore, Md.)
Published: March 22, 2021
Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.
Journal: Journal of hepatology
Published: March 10, 2021
Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria.
Journal: Cell reports
Published: November 13, 2020
Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease.
Journal: Archives of toxicology
Published: August 13, 2019
Last Updated: 09/26/2026